Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116256603 | 11625660 | 3 | F | 20140212 | 20160907 | 20151013 | 20160923 | EXP | CA-GILEAD-2014-0095630 | GILEAD | 81.00 | YR | E | F | Y | 0.00000 | 20160923 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116256603 | 11625660 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | D | 22081 | 10 | MG | TABLET | QD | |||||
116256603 | 11625660 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK | U | 0 | |||||||||
116256603 | 11625660 | 3 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
116256603 | 11625660 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 6 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 | |||||||||||
116256603 | 11625660 | 7 | C | WARFARIN | WARFARIN | 1 | U | 0 | |||||||||||
116256603 | 11625660 | 8 | C | DIGOXIN. | DIGOXIN | 1 | U | 0 | |||||||||||
116256603 | 11625660 | 9 | C | CALCIUM | CALCIUM | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 10 | C | CALCIUM | CALCIUM | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 11 | C | CALCIUM | CALCIUM | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 12 | C | TOLOXIN /00017701/ | 2 | UNK | U | 0 | |||||||||||
116256603 | 11625660 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 14 | C | OXYGEN. | OXYGEN | 1 | 3 L, UNK | U | 0 | 3 | L | ||||||||
116256603 | 11625660 | 15 | C | OXYGEN. | OXYGEN | 1 | UNK | U | 0 | ||||||||||
116256603 | 11625660 | 16 | C | OXYGEN. | OXYGEN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116256603 | 11625660 | 1 | Pulmonary arterial hypertension |
116256603 | 11625660 | 2 | Product used for unknown indication |
116256603 | 11625660 | 3 | Product used for unknown indication |
116256603 | 11625660 | 4 | Product used for unknown indication |
116256603 | 11625660 | 6 | Product used for unknown indication |
116256603 | 11625660 | 7 | Product used for unknown indication |
116256603 | 11625660 | 8 | Product used for unknown indication |
116256603 | 11625660 | 9 | Product used for unknown indication |
116256603 | 11625660 | 12 | Product used for unknown indication |
116256603 | 11625660 | 13 | Product used for unknown indication |
116256603 | 11625660 | 14 | Product used for unknown indication |
116256603 | 11625660 | 15 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
116256603 | 11625660 | DE |
116256603 | 11625660 | OT |
116256603 | 11625660 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116256603 | 11625660 | Death | |
116256603 | 11625660 | Diarrhoea | |
116256603 | 11625660 | Dyspnoea | |
116256603 | 11625660 | Faeces soft | |
116256603 | 11625660 | Melaena | |
116256603 | 11625660 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116256603 | 11625660 | 1 | 20131107 | 0 |